You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Subarachnoid haemorrhage : Nimoglad Injection is a calcium channel blocker. It works by relaxing the narrowed blood vessels in the brain so that blood can flow more easily. This prevents further brain damage after bleeding around the brain. It is given as an injection and started as soon as possible after bleeding in the brain is confirmed. Your doctor may switch to a tablet form once treatment with Nimoglad Injection is completed. Follow your doctor's instructions carefully to get the maximum benefit from this medicine.
Side effects of Nimoglad Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Nimoglad Rash Headache Stomach discomfort Nausea Decreased blood pressure Slow heart rate
How to use Nimoglad Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Nimoglad Injection works Nimoglad Injection is a calcium channel blocker. It relaxes the narrow blood vessels in the brain and makes the blood flow more easily. This prevents brain damage after bleeding around the brain.
Not Safe: Consuming alcohol with Nimoglad Injection may lead to excessive drowsiness.
Nimoglad Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Nimoglad Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Nimoglad Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nimoglad Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nimoglad Injection may not be needed in these patients. Doctor consultation is advised.
There is limited information available on the use of Nimoglad Injection in patients with liver disease. Doctor consultation is advised.
Plot No. 398, Industrial Area, Phase-1, Panchkula 134113
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 980-82
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.